Dr. Haroon will be speaking as part of the panel discussing “China Healthcare Investors: Addressing Unmet Medical Need by Cross-Border Investments” from 3:00 to 3:50.

During a recent trip to London, Dr. Z Haroon, the Chairman and General Partner of Julz, was interviewed by Biotech and Money, an influential community of senior life science decision makers.  The interview can be found here:  http://www.biotechandmoney.com/blog/investorview-julz.

Julz is attending the BioTrinity Conference in London on May 9-10, 2017.   BioTrinity is one of Europe’s leading biopartnering and investment conferences, and the largest of its type in the UK.  The conference provides a networking and partnering platform for life science companies across the world to meet under one roof and catalyze business in the industry, to ultimately help shape our healthcare future.  BioTrinity offers unique access to global life science investors, like Julz Co, big pharma executives and innovative CEO’s of emerging R&D companies seeking to make deals and grow their networks.

Julz Co is an investment management company focused on the health care industry with an emphasis on therapeutics, diagnostics, medical devices and digital healthcare. The company has offices in Chapel Hill, North Carolina, USA and Suzhou, China.  Julz typically invests in early stage biotechnology/medical device companies that have novel and proprietary technology addressing a vital market need and are driven by experienced management teams.

The Redefining Early Stage Investments (RESI) Conference will be held on April 4th 2017 in Toronto, Canada. It is an ongoing conference series that creates a global conduit between early stage life sciences companies and investors.  The conference also holds series of panels and workshops through which attendees will have the chance to hear from investors explaining current investment mandates.

Dr. Haroon will be a panelist at the 4 pm session discussing how to build cross-border partnerships in Asia in the healthtech sector. He will share insights from his 15+ years of transactional and operational experience in China.

For more information, please visit RESI’s website.

CHAPEL HILL, NC – (March 6, 2017) – Julz is attending the 15th annual eyeforpharma conference in Barcelona, Spain on March 14-16, 2017. Eyeforpharma is Europe’s largest commercial pharma meeting of 1000+ industry leaders focused on commercial innovation, customer centricity and patient engagement.

Julz Co is an investment management company based in Chapel Hill, NC and Suzhou, China, focused on financing companies in the healthcare industry with an emphasis on therapeutics, diagnostics and digital healthcare with applications in the U.S., Europe and China.